Carbohydrate vaccines-A burgeoning field of glycomics

Journal of Applied Pharmaceutical Science

Volumn 1, Issue 2, 2011, Pages 17-22

  Doshi, Gaurav M ^a   Shanbhag, Pradnya Palekar ^a   Aggarwal, Gayatri V ^a   Shahare, Mukesh D ^a   Martis, Elvis A ^a  

^a Vivekanand Education Society's College of Pharmacy   (India)

Author keywords

Glycobiology; Micro organisms; Proteomics; Vaccines

Indexed keywords

EID: 84862542092     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Borman S: Vaccines by automated synthesis. Carbohydrates Science and Technology 2002; 80: 43-44.
2. Dintzis RZ: Rational design of conjugate disease. Pediatr Res 1992; 32(4): 376-385.
3. Holemann A and Seeberger P: Carbohydrate diversity : Synthesisof glycoconjugates and complex carbohydrates. CurrOpin In Biotech 2004; 15(1): 615-622.
4. Janeway CA, Paul T. et al. Immunobiology, The Immune System in Ritter G: Serological Mointoring of GM2 Cancer Vaccine Trials. Ludwig Institute for Cancer Research, New York, 2005.
5. Vicher S, LO-Man R, Bay S. et al. : Short synthetic glycopeptides successfully induce antibody responses to carcinoma associated Tn antigen. Peptide Res 2000; 55: 173-180.
6. Apostolopoulos V, Plebanski M, McKenzie I : Carbohydratebased targets and vehicles for infectious diseases vaccines. In :Landes Bioscience. Immunobiology ofcarbohydrates ( Simon Y C Wong, ed. ) 2004
7. Bay S, Osinaga E et.al : Preparation of a multiple antigen glycopeptide (MAG) carrying the antigen : A possible approach to a synthetic carbohydrate vaccine. J Peptide Res 1997; 49: 620-625.
8. Bencomo VV, Santana FV et al.: A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 2004; 305(5683): 552-555.
9. Bertozzi CR and Kiessling LL : Chemical Glycobiology. Science 2001; 291 2357-2364.
10. Bock K, Clausen H :Complex Carbohydrates in Drug Research Structural and functional Aspects, Essentials of GlycobiologyMunksgaard, Copenhagen1994, Denmark.
11. Cancer Vaccine: Carbohydrate vaccines as immunotherapy for cancer reviewed.Immunology and Cell Biology. Vaccine Weekly 2005.
12. Carbohydrate vaccines in cancer:Immunogeneicity of Fully synthetic globo-H hexasaccharide conjugate in man. NatlAcadSci USA 96; 10: 5710-5715.
13. Casson K :Glycoscience : Biology's Newest Uncharted Frontier University of Georgia Research Magazine Spring 2004.
14. Chamberlain NR. New pneumococcal vaccine approved. www.microbes.info/resources/Articles/Medical_Microbiology/Vaccines/index.html
15. Cummings et.al :Constrium for functional Glycomics. MIT Enterprise Technology Review Jan 7. 2003.
16. Danishefsky S : Molecular and oraginc chemistry 2005 Sloan Kettering Institute. Dennis C : Sweet Revenge. Nature 2003; 423: 580-582.
17. Goldbatt D : Recent developments in bacterial conjugate vaccines. J Med Micro 1998; 47 : 563-567.
18. Health and Disease (4th Edition ed.) Current Biology Publications., part of Elsevier Science London, London, UK, 1999.
19. Hewitt MC, Snyder DA and Seeberger PH: Microarray : A versatile platform for high throughout functional glycomics. J Am ChemSoc 2002; 124: 13434
20. Jennings H J and Snood RK : In Neoglycoconjugates, preparationand application Lee YC and Lee RT. Academic; 1994 : p.325
21. Jones C : Vaccines based on the cell surface carbohydrates of pathogenic bacteria. An Acad Bras Cienc 2005; 77(2): 293-324.
22. Jones C: NMR assays for carbohydrate-based vaccines. Journal of Pharmaceutical and Biomedical Analysis 2005; 38(5): 840-850.
23. Keding SJ and Danishefsky SJ :Prospects for total synthesis :A vision for a totally synthetic vaccine targeting epithelial tumors. In : Scripps Research Institute (ed. By Kyriacos C. Nicolaou ) LA Jolla 2004, Califorina.
24. Knutson LK: Cancer vaccines : The next generation. Drug Discov Today : Therapeutic Strategies 2005; 2(4): 323-330.
25. Koganty RR., Reddish MA and Longenecker MB: Glycopeptide and carbohydrate based synthetic vaccines for immunotherapy of cancer. Drug Discovery Today 1996; 1(5): 190-198.
26. Kuberan B, Linhardt RJ: Carbohydrate based vaccines. Curr Org Chem 2000; 4: 653-677.
27. Lindberg AA: Glycoprotein vaccines. Vaccine 1999; 17(Suppl 2) 28-36.
28. Liu X and Seeberger P: A Suzuki-Miyaura coupling mediated deprotection as key to synthesis of fully lapidated malarial disaccharide. ChemCommun 2004; 1708.
29. Livingston PO : Construction of cancer vaccines with carbohydrate and protein(peptide) tumor antigens. CurrOpinImmunol 1992; 4: 624-629.
30. Livingston PO, Zhang, SL and Lloyd KO: Carbohydrate vaccines that induce antibodies against cancer 1 rationale. Cancer Immunol Immunother 1997; 45: 1-9.
31. Lo-man R, Vichier-Guerre S, Bay S. et.al. : Prophylactic and therapeutic vaccinations using a synthetic multiple antigenic glycopeptide(MAG) based on a tri-Tnglycotope. J Immunol 2001; 166: 2849-2854.
32. Marshall L : Carbohydrate research offers sugar-coated opportunities. The Scientist 1992; 6(3): 15.
33. Mosier DE, Zaldivas NM, Goldings E, Mond JJ, Scher I, Paul WE : Formation of antibody in the newborn mouse : study of T-cell independent antibody response. J Infect Dis 1977; 136: S14-S19.
34. Mosier DE, Mond JJ, Goldings EA: The ontogeny of thymic independent antibody responses invitro in normal mice and mice with an X-linked B cell defect. Immunol 1997; 119: 1874-1878.
35. Mrksich M : An Early Taste of Glycomics. Chemistry and Biology 2004; 11: 739-747.
36. Okajima M, Middleton MH, Greene G, Dintizis HM: The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. J Immunol 1989; 143: 1239-1244.
37. Park TK, Kim IJ, Hu SH, Bilodeau MT, Randoloph JT, Kwon O and Danishefsky SJ: Total synthesis and proof of structure of a human breast tumor ( Globo-H) Antigen. J Am ChemSoc 1996; 118: 11488-11500.
38. Ragupathi G, Slovin SF, Adhuri S, Sames D, Kim IJ, Kim HM, Spassova M, Bormann WG, Lloyd KO, Ragupathi G, Slovin SF. et al : Carbohydrate vaccines in cancer : immunogenecity of a Fully synthetic globo H hexasaccharide conjugate in man. Medical Sciences 1999; 96(10): 5710-5715.
39. Rebecca MW, Ouathek O, Warren JD and Danishefsky SJ: Synthetic carbohydrate based antitumor vaccines : challenges and opportunities. Expert Review of Vaccines 2005; 4: 677-685.
40. Reichel F. et al. : Synthetic carbohydrate-based vaccines : Synthesis of an L-glycerol-D-manno-heptose antigen-T-epitope lipopetide conjugate. ChemComm 1997; 2087.
41. Robbins JB, Schneerson R : Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers. J Infect Dis 1990; 161: 821-832.
42. Roy R : New trends in carbohydrate based vaccines. Drug Discovery Today : Technologies 2004; 1(3): 327-336.
43. Scher HI :A Fully synthetic GloboH carbohydrate vaccines induces a focused homoral response in prostate cancer patients : A proof of principle. AngewIntEd Engl 1999; 38: 563-566.
44. Schofield L, Hewitt MC, Evans K, Simons MA and Seeberger PH: Synthetic GPT as a candiate anti-toxic in a model of malaria. Nature 2002; 418: 785-789.
45. Seeberger P et al : A convergent versatile route to two synthetic conjugate anti-toxin malaria vaccine.ChemCommun 2004; 1706
46. Seeberger PH : Automate carbohydrate synthesis to derive chemical glycomics. ChemCommun 2003; 1115-1121.
47. Shriver Z, Raguram S and Sasisekharan R :Glycomics : A pathway to a class of a new and improved therapeutics. Drug Discovery 2004; 3: 863-873.
48. Sioud M. Therapeutic siRNAs. Trends PharmacolSci 2004; 25: 22-28.
49. Sprenger N, Gao H and Sigrist H : Polysaccharides for functional biomolecule display on surfaces. Microarrays BTi 2005; September: 12-15.
50. Stein K.E :Glycoconjugate vaccines. What next? Int.JTechnol Assessment in Health Care 1994; 10: 167-176.
51. Stein K.E : Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992; 165 Supplment1: S49-S52 : 325-334
52. Su J and Mrksich M: Using Mass spectrometery to characterize self-assembled Monolayers presenting peptides, proteins and carbohydrates. Angew Chem. Int. Ed. Engl. 2002; 41: 4715-4718.
53. Taylor ME, Drickamer K : Introduction to Glycobiology In : Oxford University Press, Oxford, 2003. 1-16
54. Teresa G, Ragupathi G, Bhutta S. et al. :Immunisation of metastatic breast cancer patients with a fully synthetic globoHconjugate : A phase trial immunology. Sloan-Kettering Institute. Laboratories of Organic Chemistry New York, 2000.
55. Varki A, Cummins R, Esko J. et.al. : Essentials of Glycobiology. In : Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2005.
56. Varki A, Cummins R, Esko J.et.al : Essentials of Glycobiology. In : Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1999.
57. Wang LX: Towardoligosaccharide-aglycopeptide-based HIVvaccines. Curr.Opin. Drug Discov. Devel. 2006; 9(2): 194-206.
58. Weintraub A: Immunology of bacterial polysaccharide antigens CarbohydrRes 2003; 338: 2539-2547.
59. Wiertz EJHJ. et al. : Identification of T-cell epitopes occuring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous, multiple peptide synthesis. J Exp Med 1992; 176: 79.
60. Wiesmuller KH. et al. : Solid phase peptide synthesis of lipopeptide. Int J Pept Protein Res 1992; 40: 255.